LOS ANGELES (Reuters) – The first preventive pill for HIV has been hailed as a landmark in the fight against AIDS in the United States, but experts say only a small percentage of those at risk will benefit from it. U.S. health regulators last month approved Gilead Sciences Inc's Truvada — already used globally to treat the human immunodeficiency virus — for preventing the infection in healthy …
